Sale!

PLA2G6 Gene Infantile Neuroaxonal Dystrophy Type 1 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The PLA2G6 Gene Infantile Neuroaxonal Dystrophy Type 1 Genetic Test is a specialized diagnostic tool designed to identify mutations in the PLA2G6 gene, which are linked to Infantile Neuroaxonal Dystrophy (INAD) Type 1. INAD Type 1 is a rare, inherited neurodegenerative disorder that typically manifests in early childhood, characterized by progressive loss of motor skills and intellectual abilities, leading to severe physical and mental disabilities. The condition is attributed to abnormalities in the PLA2G6 gene, which plays a crucial role in the maintenance of neuronal health.

This genetic test is conducted by DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The test involves analyzing the patient’s DNA, obtained through a blood sample, to detect mutations in the PLA2G6 gene that are responsible for INAD Type 1. The outcome of this test can provide crucial information for the diagnosis, management, and understanding of the disease’s progression, offering families and healthcare providers valuable insights into the condition.

The cost of the PLA2G6 Gene Infantile Neuroaxonal Dystrophy Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to accurately identify the genetic mutations associated with the disorder, offering a critical step towards the appropriate care and support for affected individuals and their families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PLA2G6 Gene Infantile neuroaxonal dystrophy type 1 Genetic Test

Test Name: PLA2G6 Gene Infantile neuroaxonal dystrophy type 1 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for PLA2G6 Gene Infantile neuroaxonal dystrophy type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PLA2G6 Gene Infantile neuroaxonal dystrophy type 1.

Test Details

The PLA2G6 gene is associated with infantile neuroaxonal dystrophy type 1 (INAD), a rare neurodegenerative disorder that typically begins in early childhood. INAD is characterized by progressive neurological deterioration, including movement problems, cognitive decline, and visual impairment.

NGS (next-generation sequencing) genetic testing can be used to analyze the PLA2G6 gene for mutations or variations that may be responsible for INAD. This type of genetic testing allows for the simultaneous analysis of multiple genes, providing a more comprehensive evaluation of the genetic factors contributing to the disease.

By identifying specific mutations or variations in the PLA2G6 gene, NGS genetic testing can help confirm a diagnosis of INAD and provide valuable information for genetic counseling and family planning. Additionally, this information may be useful for developing targeted therapies or interventions for individuals affected by this condition.

Test Name PLA2G6 Gene Infantile neuroaxonal dystrophy type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PLA2G6 Gene Infantile neuroaxonal dystrophy type 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PLA2G6 Gene Infantile neuroaxonal dystrophy type 1
Test Details

The PLA2G6 gene is associated with infantile neuroaxonal dystrophy type 1 (INAD), a rare neurodegenerative disorder that typically begins in early childhood. INAD is characterized by progressive neurological deterioration, including movement problems, cognitive decline, and visual impairment.

NGS (next-generation sequencing) genetic testing can be used to analyze the PLA2G6 gene for mutations or variations that may be responsible for INAD. This type of genetic testing allows for the simultaneous analysis of multiple genes, providing a more comprehensive evaluation of the genetic factors contributing to the disease.

By identifying specific mutations or variations in the PLA2G6 gene, NGS genetic testing can help confirm a diagnosis of INAD and provide valuable information for genetic counseling and family planning. Additionally, this information may be useful for developing targeted therapies or interventions for individuals affected by this condition.